Virtu Financial LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$59,000
-68.6%
13,137
-27.9%
0.01%
-72.2%
Q2 2021$188,000
-62.0%
18,229
-61.3%
0.02%
-48.6%
Q1 2021$495,000
-36.1%
47,054
-6.1%
0.04%
-58.3%
Q4 2020$775,000
+682.8%
50,086
+387.8%
0.08%
+950.0%
Q3 2019$99,000
-49.2%
10,267
-10.5%
0.01%
-33.3%
Q3 2018$195,000
-41.3%
11,466
-53.6%
0.01%
-33.3%
Q1 2018$332,000
+65.2%
24,710
+35.1%
0.02%
+80.0%
Q3 2017$201,00018,2930.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders